{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:32:49Z","timestamp":1787909569658,"version":"build-2784847793"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s42000-024-00576-5","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T02:02:50Z","timestamp":1719367370000},"page":"637-653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Female-specific risk factors for cardiovascular disease: an update"],"prefix":"10.1007","volume":"23","author":[{"given":"Angeliki","family":"Theodorou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios S.","family":"Karagiannakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Stefanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Kassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melpomeni","family":"Peppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Vryonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-1376","authenticated-orcid":false,"given":"Stavroula A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"576_CR1","unstructured":"World Health Organization Cardiovascular diseases (CVDs) Fact sheet. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)"},{"issue":"6","key":"576_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/01.HYP.0000223064.62762.0b","volume":"47","author":"MR Meyer","year":"2006","unstructured":"Meyer MR, Haas E, Barton M (2006) Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension 47(6):1019\u20131026. https:\/\/doi.org\/10.1161\/01.HYP.0000223064.62762.0b","journal-title":"Hypertension"},{"key":"576_CR3","doi-asserted-by":"crossref","unstructured":"Gao Z, Chen Z, Sun A, Deng X (2019) Gender differences in cardiovascular disease. Med Novel Technol Devices 100025. 410.1016\/j.medntd.2019.100025","DOI":"10.1016\/j.medntd.2019.100025"},{"issue":"1","key":"576_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","volume":"8","author":"A Iorga","year":"2017","unstructured":"Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M (2017) The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ 8(1):33. https:\/\/doi.org\/10.1186\/s13293-017-0152-8","journal-title":"Biol Sex Differ"},{"issue":"2","key":"576_CR5","first-page":"123","volume":"6","author":"M Garaulet","year":"2002","unstructured":"Garaulet M, P\u00e9rez-Llamas F, Baraza JC, Garcia-Prieto MD, Fardy PS, T\u00e9bar FJ, Zamora S (2002) Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables. J Nutr Health Aging 6(2):123\u2013126","journal-title":"J Nutr Health Aging"},{"key":"576_CR6","doi-asserted-by":"publisher","unstructured":"Yazdanyar A, Newman AB (2009) The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med.;25(4):563\u2013\u200977, vii. https:\/\/doi.org\/10.1016\/j.cger.2009.07.007","DOI":"10.1016\/j.cger.2009.07.007"},{"issue":"1","key":"576_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.01.027","volume":"241","author":"Y Appelman","year":"2015","unstructured":"Appelman Y, van Rijn BB, Ten Haaf ME, Boersma E, Peters SA (2015) Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis 241(1):211\u2013218. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.01.027","journal-title":"Atherosclerosis"},{"key":"576_CR8","first-page":"604","volume":"67","author":"C Coulam","year":"1986","unstructured":"Coulam C, Anderson S, Annegers J (1986) Incidence of premature ovarian failure. Obstet Gynecol 67:604\u2013606","journal-title":"Obstet Gynecol"},{"key":"576_CR9","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","volume":"117","author":"C Guan","year":"2022","unstructured":"Guan C, Zahid S, Minhas AS, Ouyang P, Vaught A, Baker V, Michos ED (2022) Polycystic ovary syndrome: a risk-enhancing factor for cardiovascular disease. Fertil Steril 117:924\u201335924. https:\/\/doi.org\/10.1016\/j.fertnstert.2022.03.009","journal-title":"Fertil Steril"},{"issue":"6","key":"576_CR10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.2337\/dc22-1841","volume":"46","author":"G Wang","year":"2023","unstructured":"Wang G, Buckley JP, Bartell TR, Hong X, Pearson C, Wang X (2023) Gestational diabetes Mellitus, Postpartum Lipidomic signatures, and subsequent risk of type 2 diabetes: a lipidome-wide Association study. Diabetes Care 46(6):1223\u20131230. https:\/\/doi.org\/10.2337\/dc22-1841","journal-title":"Diabetes Care"},{"key":"576_CR11","doi-asserted-by":"publisher","unstructured":"Vryonidou A, Paschou SA, Muscogiuri G, Orio F, Goulis DG MECHANISMS IN ENDOCRINOLOGY: metabolic syndrome through the female life cycle. Eur J Endocrinol 2015 173 R153\u2013R163. (https:\/\/doi.org\/10.1530\/EJE-15-0275)","DOI":"10.1530\/EJE-15-0275"},{"key":"576_CR12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1210\/jc.2010-1902)","volume":"96","author":"M Maggio","year":"2011","unstructured":"Maggio M, Ceda GP, Lauretani F, Bandinelli S, Corsi AM, Giallauria F, Guralnik JM, Zuliani G, Cattabiani C, Parrino S et al (2011) SHBG, sex hormones, and inflammatory markers in older women. J Clin Endocrinol Metab 96:1053\u20131059. https:\/\/doi.org\/10.1210\/jc.2010-1902)","journal-title":"J Clin Endocrinol Metab"},{"key":"576_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41574-020-00431-8","volume":"17","author":"GH Goossens","year":"2021","unstructured":"Goossens GH, Jocken J, Blaak E (2021) Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Reviews Endocrinol 17:47\u201366","journal-title":"Nat Reviews Endocrinol"},{"key":"576_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tips.2010.01.001","volume":"31","author":"A Cignarella","year":"2010","unstructured":"Cignarella A, Kratz M, Bolego C (2010) Emerging role of estrogen in the control of cardiometabolic disease. Trends Pharmacol Sci 31:183\u2013189","journal-title":"Trends Pharmacol Sci"},{"key":"576_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/ijms19030859","volume":"19","author":"A Trenti","year":"2018","unstructured":"Trenti A, Tedesco S, Boscaro C, Trevisi L, Bolego C, Cignarella A (2018) Estrogen, angiogenesis, immunity and cell metabolism: solving the puzzle. Int J Mol Sci 19:859","journal-title":"Int J Mol Sci"},{"key":"576_CR16","doi-asserted-by":"crossref","unstructured":"Maclaran K (2015) N. Panay. Current concepts in premature ovarian insufficiency. Women\u2019s Health 169\u2013182","DOI":"10.2217\/WHE.14.82"},{"key":"576_CR17","doi-asserted-by":"crossref","unstructured":"Lambrinoudaki I, Paschou SA, Lumsden MA, Faubion S, Makrakis E, Kalantaridou S, Panay N Premature ovarian insufficiency: a toolkit for the primary care physician. Maturitas 2021 147:53\u201363","DOI":"10.1016\/j.maturitas.2020.11.004"},{"key":"576_CR18","doi-asserted-by":"crossref","unstructured":"Ishizuka B Current understanding of the etiology, Symptomatology, and Treatment options in premature ovarian insufficiency (POI). Front Endocrinol 12:626924","DOI":"10.3389\/fendo.2021.626924"},{"key":"576_CR19","doi-asserted-by":"crossref","unstructured":"Rossetti R, Ferrari I, Bonomi M, Persani L (2017) Genetics of primary ovarian insufficiency. Clin Genet. 183\u2013198","DOI":"10.1111\/cge.12921"},{"key":"576_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1530\/EJE-18-0602","volume":"180","author":"P Anagnostis","year":"2019","unstructured":"Anagnostis P, Christou K, Artzouchaltzi AM, Gkekas N, Kosmidou N, Siolos P et al (2019) Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis. Eur J Endocrinol 180:41\u201350","journal-title":"Eur J Endocrinol"},{"key":"576_CR21","doi-asserted-by":"crossref","unstructured":"Liu J, Jin X, Liu W, Chen W, Wang L, Feng Z, Huang J The risk of long-term cardiometabolic disease in women with premature or early menopause: a systematic review and meta-analysis front. Cardiovasc Med 10:1131251","DOI":"10.3389\/fcvm.2023.1131251"},{"key":"576_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mce.2009.02.016","volume":"304","author":"A Nadal","year":"2009","unstructured":"Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB (2009) The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 304:63\u201368","journal-title":"Mol Cell Endocrinol"},{"key":"576_CR23","doi-asserted-by":"crossref","unstructured":"Paschou SA, Anagnostis P, Pavlou DI, Vryonidou A, Goulis DG (2018) Lambrinoudaki I. Diabetes in menopause: risks and management. Current Vascular Pharmacology","DOI":"10.2174\/1570161116666180625124405"},{"issue":"22","key":"576_CR24","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.jacc.2019.09.052","volume":"74","author":"MC Honigberg","year":"2019","unstructured":"Honigberg MC, Zekavat SM, Aragam K, Klarin D, Bhatt DL, Scott NS et al (2019) Long-Term Cardiovascular risk in women with hypertension during pregnancy. J Am Coll Cardiol 74(22):2743\u20132754. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.052","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"576_CR25","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/01.ede.0000165392.35273.d4","volume":"16","author":"ME Ossewaarde","year":"2005","unstructured":"Ossewaarde ME, Bots ML, Verbeek ALM, Peeters PHM, van der Graaf Y, Grobbee DE et al (2005) Age at Menopause, cause-Specific Mortality and Total Life Expectancy. Epidemiology 16(4):556\u2013562","journal-title":"Epidemiology"},{"issue":"2","key":"576_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/2047487314556004","volume":"23","author":"JE van Roeters","year":"2016","unstructured":"van Roeters JE, Heida KY, Bots ML, Hoek A (2016) Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. J Prev Cardiol 23(2):178\u2013186","journal-title":"J Prev Cardiol"},{"key":"576_CR27","doi-asserted-by":"publisher","unstructured":"Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F et al Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health 2019 4(11):e553\u2013e564. https:\/\/doi.org\/10.1016\/S2468-2667(19)30155-0","DOI":"10.1016\/S2468-2667(19)30155-0"},{"issue":"11","key":"576_CR28","doi-asserted-by":"publisher","first-page":"e006713","DOI":"10.1161\/JAHA.117.006713","volume":"6","author":"SH Ley","year":"2017","unstructured":"Ley SH, Li Y, Tobias DK, Manson JE, Rosner B, Hu FB, Rexrode KM (2017) Duration of Reproductive Life Span, Age at Menarche, and age at Menopause are Associated with Risk of Cardiovascular Disease in Women. J Am Heart Assoc 6(11):e006713. https:\/\/doi.org\/10.1161\/JAHA.117.006713","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"576_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/13697137.2015.1094784","volume":"19","author":"X-Y Tao","year":"2016","unstructured":"Tao X-Y, Zuo A-Z, Wang J-Q, Tao F-B (2016) Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric 19(1):27\u201336. https:\/\/doi.org\/10.3109\/13697137.2015.1094784","journal-title":"Climacteric"},{"issue":"7","key":"576_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","volume":"1","author":"T Muka","year":"2016","unstructured":"Muka T, Oliver-Williams C, Kunutsor S, Laven JS, Fauser BC, Chowdhury R et al (2016) Association of Age at Onset of Menopause and Time since Onset of Menopause with Cardiovascular outcomes, Intermediate Vascular traits, and all-cause mortality: a systematic review and Meta-analysis. JAMA Cardiol 1(7):767\u2013776. https:\/\/doi.org\/10.1001\/jamacardio.2016.2415","journal-title":"JAMA Cardiol"},{"issue":"10","key":"576_CR31","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.jacc.2005.12.066","volume":"47","author":"HS Kok","year":"2006","unstructured":"Kok HS, van Asselt KM, van der Schouw YT, van der Tweel I, Peeters PH, Wilson PW et al (2006) Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 47(10):1976\u20131983. https:\/\/doi.org\/10.1016\/j.jacc.2005.12.066","journal-title":"J Am Coll Cardiol"},{"key":"576_CR32","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1210\/jc.2004-0015","volume":"89","author":"SN Kalantaridou","year":"2004","unstructured":"Kalantaridou SN, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA et al (2004) Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 89:3907\u20133913. https:\/\/doi.org\/10.1210\/jc.2004-0015","journal-title":"J Clin Endocrinol Metab"},{"key":"576_CR33","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/gme.0b013e31826883f6","volume":"19","author":"CA Stuenkel","year":"2012","unstructured":"Stuenkel CA (2012) Cardiovascular risk and early menopause: cause or consequence? Menopause 19:1067\u20131069","journal-title":"Menopause"},{"key":"576_CR34","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1210\/jc.2015-2236","volume":"100","author":"CA Stuenkel","year":"2015","unstructured":"Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ (2015) Treatment of symptoms of the menopause: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 100:3975\u20134011. https:\/\/doi.org\/10.1210\/jc.2015-2236","journal-title":"J Clin Endocrinol Metab"},{"key":"576_CR35","doi-asserted-by":"crossref","unstructured":"Faubion S.S., Sood R, Kapoor E (2017) Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc 92:1842\u20131849","DOI":"10.1016\/j.mayocp.2017.08.019"},{"issue":"12","key":"576_CR36","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31(12):2841\u20132855. https:\/\/doi.org\/10.1093\/humrep\/dew218","journal-title":"Hum Reprod"},{"issue":"1","key":"576_CR37","first-page":"19","volume":"81","author":"ESHRE Rotterdam","year":"2003","unstructured":"Rotterdam ESHRE, ASRM-Sponsored PCOS Consensus Work-shop Group (2003) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19\u201325","journal-title":"Fertil Steril"},{"key":"576_CR38","first-page":"377","volume-title":"Polycystic ovary syndrome","author":"JK Zawadski","year":"1992","unstructured":"Zawadski JK (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A (ed) Polycystic ovary syndrome. Blackwell Scientific, Boston, pp 377\u2013384"},{"key":"576_CR39","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al (2009) The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456\u2013488","journal-title":"Fertil Steril"},{"key":"576_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mce.2012.10.009","volume":"373","author":"G Kosova","year":"2013","unstructured":"Kosova G, Urbanek M (2013) Genetics of the polycystic ovary syndrome. Mol Cell Endocrinol 373:29\u201338. https:\/\/doi.org\/10.1016\/j.mce.2012.10.009","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"576_CR41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33(6):981\u20131030. https:\/\/doi.org\/10.1210\/er.2011-1034","journal-title":"Endocr Rev"},{"key":"576_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X et al (2023) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res 16:9. https:\/\/doi.org\/10.1186\/s13048-022-01091-0","journal-title":"J Ovarian Res"},{"key":"576_CR43","doi-asserted-by":"publisher","first-page":"9240569","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J (2022) Association of Insulin Resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthc Eng 2022:9240569. https:\/\/doi.org\/10.1155\/2022\/9240569","journal-title":"J Healthc Eng"},{"key":"576_CR44","first-page":"302","volume":"81","author":"D Willis","year":"1996","unstructured":"Willis D, Mason H, Gilling-Smith C, Franks S (1996) Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81:302\u2013309","journal-title":"J Clin Endocrinol Metab"},{"key":"576_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jcem.76.2.8432767","volume":"76","author":"JE Nestler","year":"1993","unstructured":"Nestler JE (1993) Sex hormone-binding globulin: a marker for hyperinsulinemia and\/or insulin resistance? J Clin Endocrinol Metab 76:273\u2013274","journal-title":"J Clin Endocrinol Metab"},{"key":"576_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000494899","volume":"53","author":"DH Abbott","year":"2019","unstructured":"Abbott DH, Kraynak M, Dumesic DA, Levine JE (2019) In utero androgen excess: a developmental commonality preceding polycystic ovary syndrome? Front Horm Res 53:1\u201317. https:\/\/doi.org\/10.1159\/000494899","journal-title":"Front Horm Res"},{"issue":"10","key":"576_CR47","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","volume":"83","author":"L Ib\u00e1\u00f1ez","year":"1998","unstructured":"Ib\u00e1\u00f1ez L, Potau N, Francois I, de Zegher F (1998) Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 83(10):3558\u20133562. https:\/\/doi.org\/10.1210\/jcem.83.10.5205","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"576_CR48","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/humrep\/des027","volume":"27","author":"MJ Davies","year":"2012","unstructured":"Davies MJ, March WA, Willson KJ, Giles LC, Moore VM (2012) Birthweight and thinness at birth independently predict symptoms of polycystic ovary syndrome in adulthood. Hum Reprod 27(5):1475\u20131480. https:\/\/doi.org\/10.1093\/humrep\/des027","journal-title":"Hum Reprod"},{"key":"576_CR49","doi-asserted-by":"publisher","unstructured":"Franks S Polycystic ovary syndrome. New Engl J Med 1995 333 853\u2013861. (https:\/\/doi.org\/10.1056\/NEJM199509283331307)","DOI":"10.1056\/NEJM199509283331307"},{"key":"576_CR50","doi-asserted-by":"publisher","unstructured":"Dobbie LJ, Pittam B, Zhao SS, Alam U, Hydes TJ, Barber TM, Cuthbertson DJ (2023) Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis. Hum Reprod.;38(6):1168\u20131182. https:\/\/doi.org\/10.1093\/humrep\/dead053. PMID: 37015099","DOI":"10.1093\/humrep\/dead053"},{"issue":"2","key":"576_CR51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s12020-021-02801-2","volume":"74","author":"P Anagnostis","year":"2021","unstructured":"Anagnostis P, Paparodis RD, Bosdou JK, Bothou C, Macut D, Goulis DG, Livadas S (2021) Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies. Endocrine 74(2):245\u2013253","journal-title":"Endocrine"},{"issue":"3","key":"576_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/humrep\/des463","volume":"28","author":"NK Stepto","year":"2013","unstructured":"Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ (2013) Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod 28(3):777\u2013784. https:\/\/doi.org\/10.1093\/humrep\/des463","journal-title":"Hum Reprod"},{"issue":"10","key":"576_CR53","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1210\/jc.2017-01354","volume":"102","author":"KH Rubin","year":"2017","unstructured":"Rubin KH, Glintborg D, Nybo M, Abrahamsen B, Andersen M (2017) Development and risk factors of type 2 diabetes in a Nationwide Population of Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab 102(10):3848\u20133857. https:\/\/doi.org\/10.1210\/jc.2017-01354","journal-title":"J Clin Endocrinol Metab"},{"key":"576_CR54","doi-asserted-by":"publisher","unstructured":"Ollila MM, West S, Kein\u00e4nen-Kiukaanniemi S, Jokelainen J, Auvinen J, Puukka K et al (2017) Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study. Hum Reprod.;32(2):423\u2013431. https:\/\/doi.org\/10.1093\/humrep\/dew329. Epub 2016 Dec 28. Erratum in: Hum Reprod. 2017;32(4):968","DOI":"10.1093\/humrep\/dew329"},{"key":"576_CR55","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2)","volume":"111","author":"R Legro","year":"2001","unstructured":"Legro R, Kunselman A, Dunaif A (2001) Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111:607\u2013613. https:\/\/doi.org\/10.1016\/S0002-9343(01)00948-2)","journal-title":"Am J Med"},{"issue":"3","key":"576_CR56","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","volume":"95","author":"RA Wild","year":"2011","unstructured":"Wild RA, Rizzo M, Clifton S, Carmina E (2011) Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 95(3):1073\u20131079..e1-11","journal-title":"Fertil Steril"},{"key":"576_CR57","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","volume":"110","author":"P Kasper","year":"2021","unstructured":"Kasper P, Martin A, Lang S et al (2021) NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol 110:921\u2013937. https:\/\/doi.org\/10.1007\/s00392-020-01709-7","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"576_CR58","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/humrep\/dep380","volume":"25","author":"E Vassilatou","year":"2010","unstructured":"Vassilatou E, Lafoyianni S, Vryonidou A, Ioannidis D, Kosma L, Katsoulis K et al (2010) Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Hum Reprod 25(1):212\u2013220. https:\/\/doi.org\/10.1093\/humrep\/dep380","journal-title":"Hum Reprod"},{"key":"576_CR59","doi-asserted-by":"publisher","unstructured":"Stefanaki K, Ilias I, Paschou SA, Karagiannakis DS (2023) Hepatokines: the missing link in the development of insulin resistance and hyperandrogenism in PCOS? Hormones. 22(4):715\u2013724. https:\/\/doi.org\/10.1007\/s42000-023-00487-x","DOI":"10.1007\/s42000-023-00487-x"},{"issue":"3","key":"576_CR60","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1210\/jc.2014-3886","volume":"100","author":"R Hart","year":"2015","unstructured":"Hart R, Doherty DA (2015) The potential implications of a PCOS diagnosis on a woman\u2019s long-term health using data linkage. J Clin Endocrinol Metab 100(3):911\u2013919. https:\/\/doi.org\/10.1210\/jc.2014-3886","journal-title":"J Clin Endocrinol Metab"},{"key":"576_CR61","doi-asserted-by":"publisher","first-page":"552421","DOI":"10.3389\/fcvm.2020.552421","volume":"7","author":"J Zhang","year":"2020","unstructured":"Zhang J, Xu JH, Qu QQ, Zhong GQ (2020) Risk of Cardiovascular and cerebrovascular events in polycystic ovarian syndrome women: a Meta-analysis of Cohort studies. Front Cardiovasc Med 7:552421. https:\/\/doi.org\/10.3389\/fcvm.2020.552421","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"576_CR62","first-page":"74","volume":"70","author":"S Iftikhar","year":"2012","unstructured":"Iftikhar S, Collazo-Clavell ML, Roger VL, St Sauver J, Brown RD Jr, Cha S, Rhodes DJ (2012) Risk of cardiovascular events in patients with polycystic ovary syndrome. Neth J Med 70(2):74\u201380","journal-title":"Neth J Med"},{"issue":"1","key":"576_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/09513590.2019.1650337","volume":"36","author":"F Ramezani Tehrani","year":"2020","unstructured":"Ramezani Tehrani F, Amiri M, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E (2020) Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol 36(1):12\u201323. https:\/\/doi.org\/10.1080\/09513590.2019.1650337","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"576_CR64","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.fertnstert.2014.08.001","volume":"102","author":"NM Daan","year":"2014","unstructured":"Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW et al (2014) Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Fertil Steril 102(5):1444\u20131451e3. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.08.001","journal-title":"Fertil Steril"},{"key":"576_CR65","doi-asserted-by":"publisher","unstructured":"Subramanya V, Zhao D, Ouyang P, Ying W, Vaidya D, Ndumele CE et al Association of endogenous sex hormone levels with coronary artery calcium progression among post-menopausal women in the multi-ethnic study of atherosclerosis (MESA). J Cardiovasc Comput Tomogr 2019 Jan-Feb;13(1):41\u201347. https:\/\/doi.org\/10.1016\/j.jcct.2018.09.010","DOI":"10.1016\/j.jcct.2018.09.010"},{"key":"576_CR66","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/humupd\/dmr046","volume":"18","author":"ML Meyer","year":"2012","unstructured":"Meyer ML, Malek AM, Wild RA, Korytkowski MT, Talbott EO (2012) Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18:112\u2013126","journal-title":"Hum Reprod Update"},{"key":"576_CR67","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2265.2012.04490.x","volume":"78","author":"VS Sprung","year":"2013","unstructured":"Sprung VS, Atkinson G, Cuthbertson DJ, Pugh CJ, Aziz N, Green DJ et al (2013) Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies. Clin Endocrinol (Oxf) 78:438\u2013446","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"576_CR68","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1080\/09513590.2017.1347779","volume":"33","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Wang X, Jiang Y, Ma H, Chen L, Lai C et al (2017) Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis. Gynecol Endocrinol 33(12):904\u2013910. https:\/\/doi.org\/10.1080\/09513590.2017.1347779","journal-title":"Gynecol Endocrinol"},{"key":"576_CR69","doi-asserted-by":"publisher","unstructured":"de Groot PC, Dekkers OM, Romijn JA, Dieben SW, Helmerhorst FM (2011 Jul-Aug) PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update 17(4):495\u2013500. https:\/\/doi.org\/10.1093\/humupd\/dmr001","DOI":"10.1093\/humupd\/dmr001"},{"issue":"11","key":"576_CR70","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ et al (2019) 2019 ACC\/AHA Guideline on the primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines. Circulation 140(11):e596\u2013e646. https:\/\/doi.org\/10.1161\/CIR.0000000000000678","journal-title":"Circulation"},{"issue":"10","key":"576_CR71","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehaa1044","volume":"42","author":"AHEM Maas","year":"2021","unstructured":"Maas AHEM, Rosano G, Cifkova R, Chieffo A, van Dijken D, Hamoda H et al (2021) Cardiovascular health after menopause transition, pregnancy disorders, and other gynecologic conditions: a consensus document from European cardiologists, gynecologists, and endocrinologists. Eur Heart J 42(10):967\u2013984. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1044","journal-title":"Eur Heart J"},{"issue":"12","key":"576_CR72","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK (2013) Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab 98(12):4565\u20134592. https:\/\/doi.org\/10.1210\/jc.2013-2350","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"576_CR73","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.fertnstert.2022.04.027","volume":"118","author":"KE Elkind-Hirsch","year":"2022","unstructured":"Elkind-Hirsch KE, Chappell N, Shaler D, Storment J, Bellanger D (2022) Liraglutide 3\u00a0mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study. Fertil Steril 118(2):371\u2013381 Epub 2022 Jun 13. PMID: 35710599","journal-title":"Fertil Steril"},{"key":"576_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-14358-9_5","volume-title":"Menstrual cycle related disorders","author":"SA Paschou","year":"2019","unstructured":"Paschou SA, Goulis DG, Tarlatzis BC (2019) Polycystic ovary syndrome. In: Berga S, Genazzani A, Naftolin F, Petraglia F (eds) Menstrual cycle related disorders. ISGE Series. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-14358-9_5"},{"issue":"4","key":"576_CR75","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/jcm12041454","volume":"12","author":"S Singh","year":"2023","unstructured":"Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, Kumar M (2023) Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med 12(4):1454. https:\/\/doi.org\/10.3390\/jcm12041454","journal-title":"J Clin Med"},{"issue":"7","key":"576_CR76","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.2337\/dc11-0268","volume":"34","author":"DK Tobias","year":"2011","unstructured":"Tobias DK, Hu FB, Forman JP, Chavarro J, Zhang C (2011) Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care 34(7):1582\u20131584. https:\/\/doi.org\/10.2337\/dc11-0268","journal-title":"Diabetes Care"},{"issue":"9","key":"576_CR77","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1210\/jc.2010-0361","volume":"95","author":"R Retnakaran","year":"2010","unstructured":"Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B (2010) The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk. J Clin Endocrinol Metab 95(9):4345\u20134353. https:\/\/doi.org\/10.1210\/jc.2010-0361","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"576_CR78","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00125-019-4840-2","volume":"62","author":"CK Kramer","year":"2019","unstructured":"Kramer CK, Campbell S, Retnakaran R (2019) Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia 62(6):905\u2013914. https:\/\/doi.org\/10.1007\/s00125-019-4840-2","journal-title":"Diabetologia"},{"issue":"11","key":"576_CR79","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrendo.2012.96","volume":"8","author":"TA Buchanan","year":"2012","unstructured":"Buchanan TA, Xiang AH, Page KA (2012) Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol 8(11):639\u2013649. https:\/\/doi.org\/10.1038\/nrendo.2012.96","journal-title":"Nat Rev Endocrinol"},{"issue":"22","key":"576_CR80","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/heartjnl-2012-303237","volume":"99","author":"CT Oliver-Williams","year":"2013","unstructured":"Oliver-Williams CT, Heydon EE, Smith GC, Wood AM (2013) Miscarriage and future maternal cardiovascular disease: a systematic review and meta-analysis. Heart 99(22):1636\u20131644. https:\/\/doi.org\/10.1136\/heartjnl-2012-303237","journal-title":"Heart"},{"issue":"6","key":"576_CR81","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.116.025954","volume":"135","author":"LJ Tanz","year":"2017","unstructured":"Tanz LJ, Stuart JJ, Williams PL, Rimm EB, Missmer SA, Rexrode KM et al (2017) Preterm Delivery and maternal Cardiovascular Disease in Young and Middle-aged adult women. Circulation 135(6):578\u2013589. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.025954","journal-title":"Circulation"},{"issue":"2","key":"576_CR82","doi-asserted-by":"publisher","first-page":"e007809","DOI":"10.1161\/JAHA.117.007809","volume":"7","author":"P Wu","year":"2018","unstructured":"Wu P, Gulati M, Kwok CS, Wong CW, Narain A, O\u2019Brien S et al (2018) Preterm Delivery and Future risk of maternal Cardiovascular Disease: a systematic review and Meta-analysis. J Am Heart Assoc 7(2):e007809. https:\/\/doi.org\/10.1161\/JAHA.117.007809","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"576_CR83","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.118.036748","volume":"139","author":"SM Grandi","year":"2019","unstructured":"Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, Smith GN et al (2019) Cardiovascular Disease-related morbidity and mortality in Women with a history of pregnancy complications. Circulation 139(8):1069\u20131079. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036748","journal-title":"Circulation"},{"issue":"8","key":"576_CR84","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCULATIONAHA.117.032695","volume":"137","author":"GA Zoet","year":"2018","unstructured":"Zoet GA, Benschop L, Boersma E, Budde RPJ, Fauser BCJM, van der Graaf Y, CREW Consortium et al (2018) Prevalence of subclinical coronary artery Disease assessed by Coronary computed Tomography Angiography in 45- to 55-Year-old women with a history of Preeclampsia. Circulation 137(8):877\u2013879. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032695","journal-title":"Circulation"},{"issue":"17","key":"576_CR85","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1177\/2047487316659573","volume":"23","author":"KY Heida","year":"2016","unstructured":"Heida KY, Bots ML, de Groot CJ, van Dunn\u00e9 FM, Hammoud NM, Hoek A, Laven JS et al (2016) Cardiovascular risk management after reproductive and pregnancy-related disorders: a Dutch multidisciplinary evidence-based guideline. Eur J Prev Cardiol 23(17):1863\u20131879. https:\/\/doi.org\/10.1177\/2047487316659573","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"576_CR86","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/01.HYP.0000251522.18094.d4","volume":"49","author":"AM Germain","year":"2007","unstructured":"Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ et al (2007) Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 49(1):90\u201395. https:\/\/doi.org\/10.1161\/01.HYP.0000251522.18094.d4","journal-title":"Hypertension"},{"key":"576_CR87","doi-asserted-by":"publisher","first-page":"2070926","DOI":"10.1155\/2016\/2070926","volume":"2016","author":"S Burlina","year":"2016","unstructured":"Burlina S, Dalfr\u00e0 MG, Chilelli NC, Lapolla A (2016) Gestational diabetes Mellitus and Future Cardiovascular Risk: an update. Int J Endocrinol 2016:2070926. https:\/\/doi.org\/10.1155\/2016\/2070926","journal-title":"Int J Endocrinol"},{"issue":"4","key":"576_CR88","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ajog.2013.09.020","volume":"210","author":"CL Robbins","year":"2014","unstructured":"Robbins CL, Hutchings Y, Dietz PM, Kuklina EV, Callaghan WM (2014) History of preterm birth and subsequent cardiovascular disease: a systematic review. Am J Obstet Gynecol 210(4):285\u2013297. https:\/\/doi.org\/10.1016\/j.ajog.2013.09.020","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"576_CR89","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1210\/jc.2014-3761","volume":"100","author":"VR Aroda","year":"2015","unstructured":"Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, Diabetes Prevention Program Research Group et al (2015) The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab 100(4):1646\u20131653. https:\/\/doi.org\/10.1210\/jc.2014-3761","journal-title":"J Clin Endocrinol Metab"},{"key":"576_CR90","doi-asserted-by":"publisher","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS et al (2019) 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines. Circulation 139(25):e1082\u2013e1143. https:\/\/doi.org\/10.1161\/CIR.0000000000000625","DOI":"10.1161\/CIR.0000000000000625"},{"issue":"4","key":"576_CR91","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s1047-2797(97)00207-x","volume":"8","author":"GS Cooper","year":"1998","unstructured":"Cooper GS, Sandler DP (1998) Age at natural menopause and mortality. Ann Epidemiol 8(4):229\u2013235. https:\/\/doi.org\/10.1016\/s1047-2797(97)00207-x","journal-title":"Ann Epidemiol"},{"issue":"6","key":"576_CR92","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/ije\/dyr134","volume":"40","author":"LG Gallagher","year":"2011","unstructured":"Gallagher LG, Davis LB, Ray RM, Psaty BM, Gao DL, Checkoway H, Thomas DB (2011) Reproductive history and mortality from cardiovascular disease among women textile workers in Shanghai, China. Int J Epidemiol 40(6):1510\u20131518. https:\/\/doi.org\/10.1093\/ije\/dyr134","journal-title":"Int J Epidemiol"},{"issue":"4","key":"576_CR93","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.maturitas.2006.11.004","volume":"56","author":"JS Hong","year":"2007","unstructured":"Hong JS, Yi SW, Kang HC, Jee SH, Kang HG, Bayasgalan G, Ohrr H (2007) Age at menopause and cause-specific mortality in South Korean women: Kangwha Cohort Study. Maturitas 56(4):411\u2013419. https:\/\/doi.org\/10.1016\/j.maturitas.2006.11.004","journal-title":"Maturitas"},{"issue":"10","key":"576_CR94","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/archinte.159.10.1061","volume":"159","author":"FB Hu","year":"1999","unstructured":"Hu FB, Grodstein F, Hennekens CH, Colditz GA, Johnson M, Manson JE, Rosner B, Stampfer MJ (1999) Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 159(10):1061\u20131066. https:\/\/doi.org\/10.1001\/archinte.159.10.1061","journal-title":"Arch Intern Med"},{"issue":"2","key":"576_CR95","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.maturitas.2005.04.009","volume":"53","author":"E L\u00f8kkegaard","year":"2006","unstructured":"L\u00f8kkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT (2006) The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas 53(2):226\u2013233. https:\/\/doi.org\/10.1016\/j.maturitas.2005.04.009","journal-title":"Maturitas"},{"key":"576_CR96","doi-asserted-by":"publisher","unstructured":"Baba Y, Ishikawa S, Amagi Y, Kayaba K, Gotoh T, Kajii E Premature menopause is associated with increased risk of cerebral infarction in Japanese women. Menopause 2010 May-Jun;17(3):506\u2013510. https:\/\/doi.org\/10.1097\/gme.0b013e3181c7dd41","DOI":"10.1097\/gme.0b013e3181c7dd41"},{"issue":"6","key":"576_CR97","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3346\/jkms.2005.20.6.1053","volume":"20","author":"SH Choi","year":"2005","unstructured":"Choi SH, Lee SM, Kim Y, Choi NK, Cho YJ, Park BJ (2005) Natural menopause and risk of stroke in elderly women. J Korean Med Sci 20(6):1053\u20131058. https:\/\/doi.org\/10.3346\/jkms.2005.20.6.1053","journal-title":"J Korean Med Sci"},{"issue":"7","key":"576_CR98","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1161\/01.STR.0000131746.49082.5c","volume":"35","author":"BK Jacobsen","year":"2004","unstructured":"Jacobsen BK, Heuch I, Kv\u00e5le G (2004) Age at natural menopause and stroke mortality: a cohort study with 3561 stroke deaths during 37-year follow-up. Stroke 35(7):1548\u20131551. https:\/\/doi.org\/10.1161\/01.STR.0000131746.49082.5c","journal-title":"Stroke"},{"issue":"8","key":"576_CR99","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1161\/STROKEAHA.120.030558","volume":"52","author":"SJGC Welten","year":"2021","unstructured":"Welten SJGC, Onland-Moret NC, Boer JMA, Verschuren WMM, van der Schouw YT (2021) Age at menopause and risk of ischemic and Hemorrhagic Stroke. Stroke 52(8):2583\u20132591. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030558","journal-title":"Stroke"},{"key":"576_CR100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.maturitas.2018.08.012","volume":"117","author":"AA Roman Lay","year":"2018","unstructured":"Roman Lay AA, do Nascimento CF, de Oliveira Duarte YA, Porto Chiavegatto Filho AD (2018) Age at natural menopause and mortality: a survival analysis of elderly residents of S\u00e3o Paulo, Brazil. Maturitas 117:29\u201333. https:\/\/doi.org\/10.1016\/j.maturitas.2018.08.012","journal-title":"Maturitas"},{"issue":"3","key":"576_CR101","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.maturitas.2013.04.003","volume":"75","author":"S Li","year":"2013","unstructured":"Li S, Rosenberg L, Wise LA, Boggs DA, LaValley M, Palmer JR (2013) Age at natural menopause in relation to all-cause and cause-specific mortality in a follow-up study of US black women. Maturitas 75(3):246\u2013252. https:\/\/doi.org\/10.1016\/j.maturitas.2013.04.003","journal-title":"Maturitas"},{"issue":"2","key":"576_CR102","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000521728","volume":"87","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Zhang X, Ni Y (2022) Association between Polycystic Ovarian Syndrome and Risk of Gestational Diabetes Mellitus: a Meta-analysis. Gynecol Obstet Invest 87(2):150\u2013158. https:\/\/doi.org\/10.1159\/000521728","journal-title":"Gynecol Obstet Invest"},{"issue":"7","key":"576_CR103","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/humrep\/deaa099","volume":"35","author":"G Mills","year":"2020","unstructured":"Mills G, Badeghiesh A, Suarthana E, Baghlaf H, Dahan MH (2020) Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Hum Reprod 35(7):1666\u20131674. https:\/\/doi.org\/10.1093\/humrep\/deaa099","journal-title":"Hum Reprod"},{"issue":"51","key":"576_CR104","doi-asserted-by":"publisher","first-page":"e4863","DOI":"10.1097\/MD.0000000000004863","volume":"95","author":"HF Yu","year":"2016","unstructured":"Yu HF, Chen HS, Rao DP, Gong J (2016) Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Med (Baltim) 95(51):e4863. https:\/\/doi.org\/10.1097\/MD.0000000000004863","journal-title":"Med (Baltim)"},{"key":"576_CR105","doi-asserted-by":"publisher","unstructured":"Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS (2006 Nov-Dec) A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12(6):673\u2013683. https:\/\/doi.org\/10.1093\/humupd\/dml036","DOI":"10.1093\/humupd\/dml036"},{"issue":"1","key":"576_CR106","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.fertnstert.2018.09.013","volume":"111","author":"S Zhu","year":"2019","unstructured":"Zhu S, Zhang B, Jiang X, Li Z, Zhao S, Cui L, Chen ZJ (2019) Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril 111(1):168\u2013177. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.09.013","journal-title":"Fertil Steril"},{"issue":"6","key":"576_CR107","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","volume":"26","author":"V Wekker","year":"2020","unstructured":"Wekker V, van Dammen L, Koning A, Heida KY, Painter RC, Limpens J, Laven JSE, van Roeters JE, Roseboom TJ, Hoek A (2020) Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update 26(6):942\u2013960. https:\/\/doi.org\/10.1093\/humupd\/dmaa029","journal-title":"Hum Reprod Update"},{"key":"576_CR108","doi-asserted-by":"publisher","unstructured":"Moran LJ, Misso ML, Wild RA, Norman RJ Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010 Jul-Aug;16(4):347\u2013363. https:\/\/doi.org\/10.1093\/humupd\/dmq001","DOI":"10.1093\/humupd\/dmq001"},{"issue":"4","key":"576_CR109","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/humupd\/dmy007","volume":"24","author":"NS Kakoly","year":"2018","unstructured":"Kakoly NS, Khomami MB, Joham AE, Cooray SD, Misso ML, Norman RJ, Harrison CL, Ranasinha S, Teede HJ, Moran LJ (2018) Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update 24(4):455\u2013467. https:\/\/doi.org\/10.1093\/humupd\/dmy007","journal-title":"Hum Reprod Update"},{"issue":"23","key":"576_CR110","doi-asserted-by":"publisher","first-page":"33715","DOI":"10.18632\/oncotarget.9553","volume":"7","author":"L Zhao","year":"2016","unstructured":"Zhao L, Zhu Z, Lou H, Zhu G, Huang W, Zhang S, Liu F (2016) Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis. Oncotarget 7(23):33715\u201333721. https:\/\/doi.org\/10.18632\/oncotarget.9553","journal-title":"Oncotarget"},{"issue":"2","key":"576_CR111","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ijcard.2014.06.079","volume":"176","author":"SA Anderson","year":"2014","unstructured":"Anderson SA, Barry JA, Hardiman PJ (2014) Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysis. Int J Cardiol 176(2):486\u2013487. https:\/\/doi.org\/10.1016\/j.ijcard.2014.06.079","journal-title":"Int J Cardiol"},{"issue":"2","key":"576_CR112","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/1464727002000198781","volume":"3","author":"S Wild","year":"2000","unstructured":"Wild S, Pierpoint T, Jacobs H, McKeigue P (2000) Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 3(2):101\u2013105. https:\/\/doi.org\/10.1080\/1464727002000198781","journal-title":"Hum Fertil (Camb)"},{"issue":"39","key":"576_CR113","doi-asserted-by":"publisher","first-page":"e12608","DOI":"10.1097\/MD.0000000000012608","volume":"97","author":"DC Ding","year":"2018","unstructured":"Ding DC, Chen W, Wang JH, Lin SZ (2018) Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: a population-based cohort study in Taiwan. Med (Baltim) 97(39):e12608. https:\/\/doi.org\/10.1097\/MD.0000000000012608","journal-title":"Med (Baltim)"},{"issue":"5","key":"576_CR114","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","volume":"87","author":"CG Solomon","year":"2002","unstructured":"Solomon CG, Hu FB, Dunaif A, Rich-Edwards JE, Stampfer MJ, Willett WC, Speizer FE, Manson JE (2002) Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 87(5):2013\u20132017. https:\/\/doi.org\/10.1210\/jcem.87.5.8471","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"576_CR115","doi-asserted-by":"publisher","first-page":"e3369","DOI":"10.1210\/clinem\/dgab392","volume":"106","author":"TR Berni","year":"2021","unstructured":"Berni TR, Morgan CL, Rees DA (2021) Women with polycystic ovary Syndrome have an increased risk of Major Cardiovascular events: a Population Study. J Clin Endocrinol Metab 106(9):e3369\u2013e3380. https:\/\/doi.org\/10.1210\/clinem\/dgab392","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"576_CR116","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1177\/2047487320939674","volume":"28","author":"C Oliver-Williams","year":"2021","unstructured":"Oliver-Williams C, Vassard D, Pinborg A, Schmidt L (2021) Risk of cardiovascular disease for women with polycystic ovary syndrome: results from a national Danish registry cohort study. Eur J Prev Cardiol 28(12):e39\u2013e41. https:\/\/doi.org\/10.1177\/2047487320939674","journal-title":"Eur J Prev Cardiol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00576-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-024-00576-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00576-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T06:12:24Z","timestamp":1730095944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-024-00576-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":116,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1007\/s42000-024-00576-5","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"3 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}